Skip to main navigation
Go to Indivior Pharmaceuticals, Inc. corporate website
  • Overview
  • News & Events
    • Results, Reports & Presentations
    • News Releases
    • Events
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Shareholder Info
    • Redomiciliation
    • London Delisting
    • Managing Your Shares
    • Shareholder Meetings
    • Investor FAQs
  • Governance
    • Governance Overview
    • Committees
    • Tax Strategy
  • Financials
    • SEC Filings
    • RNS Filings
  • Resources
    • Contact Us
    • Alerts Service
News & Events
  • Results, Reports & Presentations
  • News Releases
  • Events

News Releases

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
February 22, 2017
Indivior PLC FY 2016 Financial Results
February 3, 2017
Indivior PLC – Appointment of Non-Executive Director
February 3, 2017
Chief Financial Officer Announcement
January 11, 2017
Shaun Thaxter, CEO of Indivior PLC presented at the JP Morgan Healthcare Conference in San Francisco on January 11, 2017
  • First page «
  • Previous page ‹
  • …
  • Page 2
  • Page 3
  • Current page 4
Displaying 31 - 34 of 34

Investor Contact

person Jason Thompson
Work Vice President, Investor Relations
drafts InvestorRelations@indivior.com

Subscribe to our Email Alerts

Indivior Pharmaceuticals, Inc. Logo
Indivior Pharmaceuticals, Inc. Logo
© 2026 Indivior Pharmaceuticals, Inc.
This site is intended for US audiences
INDIVIOR is a registered trademark of Indivior UK Limited
Explore
  • Our Company
  • Our Science
  • Our Products
  • Our Impact
Useful Links
  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Cookie Policy
  • Product Query or Adverse Event
Get in touch
  • Contact Us
  • LinkedIn
  • X
  • Our Social Media Community Guidelines
Search Investors